FDC P/B Ratio
FDC (FDC) P/B ratio is 2.5 (Moderate), book value per share ₹1425.62 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. View FDC 52-week for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
FDC P/B Ratio — Valuation Insights & Book Value Analysis
FDC price-to-book ratio interpretation, valuation status and historical context — current P/B 2.5 (Moderate). For live price, earnings yield and the full fundamental profile, see FDC stock price BSE.
- Current PB is 701.3% above historical average
- Trading at premium to sector average PB of -0.33
FDC P/B Ratio Historical Trend
FDC annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with FDC stock valuation models to assess whether the stock is under or overvalued.
FDC Historical P/B Ratio — Book Value Per Share & Year-End Price
FDC annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.3 | ₹1425.62 | ₹423.10 | ₹2,281 | Low |
| 2024 | 0.38 | ₹1310.62 | ₹499.45 | ₹2,097 | Low |
| 2023 | 0.34 | ₹1165.29 | ₹396.45 | ₹1,981 | Low |
| 2022 | 0.24 | ₹1150.59 | ₹270.85 | ₹1,956 | Low |
| 2021 | 0.3 | ₹1020.0 | ₹304.20 | ₹1,734 | Low |
FDC vs Healthcare Peers — P/B Ratio Comparison
FDC P/B 2.5 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |